Sense Biodetection is based in Abingdon, United Kingdom. It has raised $79M in total funding. Latest round: Series B.
Sense Biodetection is based in Abingdon, United Kingdom. Sense Biodetection has raised $79M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Sense Biodetection runs through 2021; nothing later has been disclosed. Investors on record include Koch Disruptive Technologies, Cambridge Innovation Capital, Earlybird Health, Mercia Asset Management, Gov.uk, Sherlock Biosciences. 6 distinct backers are named across the disclosed rounds.
We update the Sense Biodetection record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Abingdon and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026